There are a number of lesser-known lung cancer warning signs including pins and needle like pain that impacts the arm, shoulder or chest.
Lung cancer is the most common type of cancer in Scotland with around 5,500 cases diagnosed each year, according to Scottish Government figures.
Most people diagnosed with lung cancer are 60 years old or older, with smokers also more likely to suffer. The illness can also be caused by second-hand smoke as well as radiation and substances such as asbestos, chromium and nickel compounds, reports the Mirror. However, younger people and non-smokers may also be diagnosed.
However, there are other, lesser known signs that should also be looked out for - such as pain or weakness in your shoulder. Clubbing of the fingers is also linked to lung cancer. This is where the tips of the fingers become swollen due to lack of oxygen. Cancerous cells can also release large quantities of hormones that can cause symptoms experienced in other parts of the body. It means that some may experience extreme fatigue and weight loss.
However, it is important to note that experiencing any symptoms listed above does not necessarily mean you have lung cancer and can instead be linked to many other, less serious health conditions.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
New trial shows promise of combination neoadjuvant immunotherapy for lung cancerPatients with stage 1–3 non-small cell lung cancer (NSCLC) given a combination immunotherapy prior to surgery (neoadjuvant) had a better major pathological response (10% or less residual cancer) when the cancer was removed than those who took a single immunotherapy agent alone, according to results of a novel multicenter phase 2 NeoCOAST platform trial that included two investigators from the Johns Hopkins Kimmel Cancer Center and its Bloomberg-Kimmel Institute for Cancer Immunotherapy.
Lire la suite »
Combination immunotherapy outperforms durvalumab monotherapy in neoadjuvant NSCLCCombination immunotherapy with the anti-PD-L1 monoclonal antibody durvalumab and other novel agents outperforms durvalumab alone in the neoadjuvant (pre-surgical) setting for early-stage non-small-cell lung cancer (NSCLC), according to researchers at The University of Texas MD Anderson Cancer Center.
Lire la suite »
When the XL Bully will be banned in the UK and how the ban could workThe ban comes after an attack on an 11-year-old girl in Birmingham by an American XL Bully last week which left her with shoulder and arm injuries
Lire la suite »
Tom Lawrence insists Rangers stars have Michael Beale's back amid derby falloutThe attacking star insists the player will stand shoulder-to-shoulder with their gaffer.
Lire la suite »
New trial shows promise of combination neoadjuvant immunotherapy for lung cancerPatients with stage 1–3 non-small cell lung cancer (NSCLC) given a combination immunotherapy prior to surgery (neoadjuvant) had a better major pathological response (10% or less residual cancer) when the cancer was removed than those who took a single immunotherapy agent alone, according to results of a novel multicenter phase 2 NeoCOAST platform trial that included two investigators from the Johns Hopkins Kimmel Cancer Center and its Bloomberg-Kimmel Institute for Cancer Immunotherapy.
Lire la suite »